| Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma SS Neelapu, FL Locke, NL Bartlett, LJ Lekakis, DB Miklos, CA Jacobson, ... New England Journal of Medicine 377 (26), 2531-2544, 2017 | 5584 | 2017 |
| ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells DW Lee, BD Santomasso, FL Locke, A Ghobadi, CJ Turtle, JN Brudno, ... Biology of blood and marrow transplantation 25 (4), 625-638, 2019 | 2769 | 2019 |
| Chimeric antigen receptor T-cell therapy—assessment and management of toxicities SS Neelapu, S Tummala, P Kebriaei, W Wierda, C Gutierrez, FL Locke, ... Nature reviews Clinical oncology 15 (1), 47-62, 2018 | 2338 | 2018 |
| Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1 KV Komanduri, MN Viswanathan, ED Wieder, DK Schmidt, BM Bredt, ... Nature medicine 4 (8), 953-956, 1998 | 506 | 1998 |
| Maintenance therapy with low‐dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: a … M De Lima, S Giralt, PF Thall, L de Padua Silva, RB Jones, K Komanduri, ... Cancer 116 (23), 5420-5431, 2010 | 501 | 2010 |
| Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing KV Komanduri, LS St. John, M De Lima, J McMannis, S Rosinski, ... Blood, The Journal of the American Society of Hematology 110 (13), 4543-4551, 2007 | 360 | 2007 |
| Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial BA Wilky, MM Trucco, TK Subhawong, V Florou, W Park, D Kwon, ... The lancet oncology 20 (6), 837-848, 2019 | 348 | 2019 |
| Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial M De Lima, J McMannis, A Gee, K Komanduri, D Couriel, BS Andersson, ... Bone marrow transplantation 41 (9), 771-778, 2008 | 338 | 2008 |
| Direct evidence for thymic function in adult humans JF Poulin, MN Viswanathan, JM Harris, KV Komanduri, E Wieder, ... The Journal of experimental medicine 190 (4), 479-486, 1999 | 300 | 1999 |
| Acute graft‐versus‐host disease: pathophysiology, clinical manifestations, and management D Couriel, H Caldera, R Champlin, K Komanduri Cancer 101 (9), 1936-1946, 2004 | 287 | 2004 |
| Aspergillus fumigatus suppresses the human cellular immune response via gliotoxin-mediated apoptosis of monocytes M Stanzani, E Orciuolo, R Lewis, DP Kontoyiannis, SLR Martins, ... Blood 105 (6), 2258-2265, 2005 | 283 | 2005 |
| Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells E Özdemir, LS St. John, G Gillespie, S Rowland-Jones, RE Champlin, ... Blood, The Journal of the American Society of Hematology 100 (10), 3690-3697, 2002 | 274 | 2002 |
| Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events MV Maus, S Alexander, MR Bishop, JN Brudno, C Callahan, ML Davila, ... Journal for immunotherapy of cancer 8 (2), e001511, 2020 | 248 | 2020 |
| Detection of gliotoxin in experimental and human aspergillosis RE Lewis, NP Wiederhold, J Chi, XY Han, KV Komanduri, ... Infection and immunity 73 (1), 635-637, 2005 | 237 | 2005 |
| Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)–an expert opinion from the European Society for Blood and Marrow … AJ Kansagra, NV Frey, M Bar, TW Laetsch, PA Carpenter, BN Savani, ... Bone marrow transplantation 54 (11), 1868-1880, 2019 | 210* | 2019 |
| Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution V Florou, AE Rosenberg, E Wieder, KV Komanduri, D Kolonias, ... Journal for immunotherapy of cancer 7, 1-8, 2019 | 184 | 2019 |
| Use of chimeric antigen receptor T cell therapy in clinical practice for relapsed/refractory aggressive B cell non-Hodgkin lymphoma: an expert panel opinion from the American … T Jain, M Bar, AJ Kansagra, EA Chong, SK Hashmi, SS Neelapu, M Byrne, ... Biology of Blood and Marrow Transplantation 25 (12), 2305-2321, 2019 | 180 | 2019 |
| National Marrow Donor Program–sponsored multicenter, phase II trial of HLA-mismatched unrelated donor bone marrow transplantation using post-transplant cyclophosphamide BE Shaw, AM Jimenez-Jimenez, LJ Burns, BR Logan, F Khimani, ... Journal of clinical oncology 39 (18), 1971-1982, 2021 | 166 | 2021 |
| The natural history and molecular heterogeneity of HIV-associated primary malignant lymphomatous effusions KV Komanduri, JA Luce, MS McGrath, BG Herndier, VL Ng JAIDS Journal of Acquired Immune Deficiency Syndromes 13 (3), 215-226, 1996 | 165 | 1996 |
| Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies E Özdemir, RM Saliba, RE Champlin, DR Couriel, SA Giralt, M De Lima, ... Bone marrow transplantation 40 (2), 125-136, 2007 | 164 | 2007 |
Sergio GiraltMemorial Sloan Kettering Cancer CenterVerified email at mskcc.org
